Literature DB >> 24573877

Synchronous rectal adenocarcinoma and anal canal adenocarcinoma.

Jin Gu1, Jiyou Li, Yunfeng Yao, Aiping Lu, Hongyi Wang.   

Abstract

It is difficult to distinguish a rectal carcinoma with anal metastases from coexistent synchronous anorectal carcinomas. The therapeutic strategy for rectal and anal carcinoma is so different that it should be clearly identified. Here, we report on the case of a 63-year-old man who presented with an upper-third rectal adenocarcinoma. Five months after resection, he developed an adenocarcinoma in the anal canal. The histological slides of both tumors were reviewed and immunohistochemical studies for cytokeratins (CKs) 7 and 20 were performed. The index tumor demonstrated CK 7-/CK 20+ and the second showed CK7+/CK20+. For this reason, we believe the present case had synchronous adenocarcinomas arising from anal canal and the rectum separately. It is very important to differentiate the anorectal lesions pathologically because of the impact on the therapeutic options available, especially for the lesion arising in the anal canal.

Entities:  

Year:  2007        PMID: 24573877     DOI: 10.1007/s11684-007-0064-9

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  22 in total

1.  Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases.

Authors:  C G MOERTEL; J A BARGEN; M B DOCKERTY
Journal:  Gastroenterology       Date:  1958-01       Impact factor: 22.682

Review 2.  Treatment of colon and rectal cancer.

Authors:  David Blumberg; Ramesh K Ramanathan
Journal:  J Clin Gastroenterol       Date:  2002-01       Impact factor: 3.062

3.  Adenocarcinoma of the anal ducts. A series of 21 cases.

Authors:  S L Jensen; M H Shokouh-Amiri; K Hagen; H Harling; O V Nielsen
Journal:  Dis Colon Rectum       Date:  1988-04       Impact factor: 4.585

Review 4.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

Review 5.  Epidemiology of colorectal cancer.

Authors:  Peter Boyle; Maria Elena Leon
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

6.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

7.  Synchronous colorectal carcinoma: clinico-pathological features and prognosis.

Authors:  Masatoshi Oya; Shuhei Takahashi; Takashi Okuyama; Masahiko Yamaguchi; Yoshihiko Ueda
Journal:  Jpn J Clin Oncol       Date:  2003-01       Impact factor: 3.019

8.  Chemoradiation for adenocarcinoma of the anus.

Authors:  Michael Papagikos; Christopher H Crane; John Skibber; Nora A Janjan; Barry Feig; Miguel A Rodriguez-Bigas; Arthur Hung; Robert A Wolff; Marc Delclos; Edward Lin; Karen Cleary
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

Review 9.  Cancer of the anal region.

Authors:  Lisa Licitra; Silvia Spinazzé; Roberto Doci; T R Jeffry Evans; Gunnar Tanum; Michel Ducreux
Journal:  Crit Rev Oncol Hematol       Date:  2002-07       Impact factor: 6.312

10.  Adenocarcinoma of the anal glands. Results of a survey.

Authors:  M E Abel; Y S Chiu; T R Russell; P A Volpe
Journal:  Dis Colon Rectum       Date:  1993-04       Impact factor: 4.585

View more
  1 in total

Review 1.  Synchronous Squamous Cell Carcinoma of the Anorectum and Proctosigmoid-a Case Report.

Authors:  Y C Madhu
Journal:  Indian J Surg       Date:  2017-12-23       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.